Results 91 to 100 of about 31,022 (120)
Correction: Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients. [PDF]
BMC Cardiovasc DisordEsteban-Fernández A, López-Fernández S, Pastor-Pérez FJ, Pérez-Rivera JÁ, Bonilla-Palomas JL, Cobo-Marcos M, García-Pinilla JM, Almenar-Bonet L, Fluviá-Brugués P, Bermúdez-Jiménez FJ, Goena-Vives C, López-López A, Gómez-Otero I, TIDY-HF researchers. +13 moreeuropepmc +1 more sourcePersonalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial.
JAMA NeurolCamps-Renom P, Guasch-Jiménez M, Álvarez-Cienfuegos J, López-Hernández N, Rodríguez-Campello A, Tejada-Meza H, López-Mesonero L, Albert-Lacal L, Freijo-Guerrero MM, Tarruella-Hernández D, Flores A, Cabezas-Rodríguez JA, Fernández-Vidal JM, Martínez-Domeño A, Pérez de la Ossa N, Ramos-Pachón A, Aguilera-Simón A, Marín R, Ezcurra-Díaz G, Lambea-Gil Á, Silva Y, Corona-García DJ, Giralt-Steinhauer E, Marta-Moreno J, Vizcaya-Gaona JA, Sanz-Monllor A, Luna A, López Morales M, Ustrell X, Moniche F, Solà-Roca J, Wang X, Anderson CS, Prats-Sánchez L, Martí-Fàbregas J, HOPE Study Group. +35 moreeuropepmc +1 more sourcePathology and Genetics in a Global Cohort of Parkinsonian Disorders.
JAMA NeurolWu LY, du Toit T, Georgiades T, Stafford EJ, Levine K, Fang ZH, Jasaityte S, Martinez AG, Cullinane P, De Pablo-Fernandez E, Blauwendraat C, Singleton AB, Scholz SW, Traynor BJ, Wood N, Hardy J, Chinnery P, Houlden H, Cain R, Troakes C, Chelban V, Serrano GE, Gveric D, McLean C, Love S, King A, Robinson AC, Roncaroli F, Shepherd C, Halliday G, Parkkinen L, Morris CM, Smith C, Beach TG, Gentleman S, Warner TT, Lashley T, Jaunmuktane Z, Real R, Morris HR, Global Parkinson’s Genetic Program (GP2). +40 moreeuropepmc +1 more sourceSome of the next articles are maybe not open access.
